PL202206B1 - Kompozycja pokarmowa dla psów oraz jej zastosowanie - Google Patents
Kompozycja pokarmowa dla psów oraz jej zastosowanieInfo
- Publication number
- PL202206B1 PL202206B1 PL350157A PL35015700A PL202206B1 PL 202206 B1 PL202206 B1 PL 202206B1 PL 350157 A PL350157 A PL 350157A PL 35015700 A PL35015700 A PL 35015700A PL 202206 B1 PL202206 B1 PL 202206B1
- Authority
- PL
- Poland
- Prior art keywords
- dietary
- pyrophosphate
- pieces
- meq
- dog food
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 210000004394 hip joint Anatomy 0.000 title abstract description 24
- 208000005137 Joint instability Diseases 0.000 title description 11
- 206010070874 Joint laxity Diseases 0.000 title description 10
- 235000005911 diet Nutrition 0.000 claims abstract description 93
- 239000000203 mixture Substances 0.000 claims abstract description 87
- 241000282472 Canis lupus familiaris Species 0.000 claims abstract description 70
- 230000000378 dietary effect Effects 0.000 claims abstract description 69
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims abstract description 53
- 235000011180 diphosphates Nutrition 0.000 claims abstract description 53
- 235000013305 food Nutrition 0.000 claims abstract description 52
- 230000037213 diet Effects 0.000 claims abstract description 24
- 235000019820 disodium diphosphate Nutrition 0.000 claims abstract description 8
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 claims abstract description 8
- 150000001450 anions Chemical class 0.000 claims description 18
- 235000019737 Animal fat Nutrition 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 17
- 235000016709 nutrition Nutrition 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 235000013312 flour Nutrition 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 6
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 6
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 5
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 5
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 235000004251 balanced diet Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 206010023204 Joint dislocation Diseases 0.000 abstract description 11
- 208000036426 canine hip dysplasia Diseases 0.000 abstract description 2
- 229940048084 pyrophosphate Drugs 0.000 description 39
- 208000029078 coronary artery disease Diseases 0.000 description 25
- 210000001624 hip Anatomy 0.000 description 16
- 239000002245 particle Substances 0.000 description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 description 12
- 239000011707 mineral Substances 0.000 description 12
- 235000010755 mineral Nutrition 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 10
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 241000282465 Canis Species 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 7
- 210000000588 acetabulum Anatomy 0.000 description 7
- 239000001506 calcium phosphate Substances 0.000 description 7
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 7
- 229940038472 dicalcium phosphate Drugs 0.000 description 7
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 201000008482 osteoarthritis Diseases 0.000 description 7
- 240000008042 Zea mays Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 230000018678 bone mineralization Effects 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- -1 dicalcium phosphate Chemical compound 0.000 description 4
- 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 206010073767 Developmental hip dysplasia Diseases 0.000 description 3
- 108010068370 Glutens Proteins 0.000 description 3
- 208000007446 Hip Dislocation Diseases 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008468 bone growth Effects 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 235000021312 gluten Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000020940 control diet Nutrition 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/26—Compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/247,763 US6261591B1 (en) | 1999-02-09 | 1999-02-09 | Method for reducing hip joint laxity |
| PCT/US2000/003186 WO2000047049A1 (en) | 1999-02-09 | 2000-02-08 | Method for reducing hip joint laxity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL350157A1 PL350157A1 (en) | 2002-11-18 |
| PL202206B1 true PL202206B1 (pl) | 2009-06-30 |
Family
ID=22936269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL350157A PL202206B1 (pl) | 1999-02-09 | 2000-02-08 | Kompozycja pokarmowa dla psów oraz jej zastosowanie |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6261591B1 (enExample) |
| EP (1) | EP1150569B1 (enExample) |
| JP (2) | JP4080695B2 (enExample) |
| KR (1) | KR100676589B1 (enExample) |
| AU (1) | AU776992B2 (enExample) |
| BR (1) | BR0008089A (enExample) |
| CA (1) | CA2359874C (enExample) |
| DE (1) | DE60028935T2 (enExample) |
| ES (1) | ES2265922T3 (enExample) |
| HK (1) | HK1040592B (enExample) |
| HU (1) | HUP0105485A2 (enExample) |
| PL (1) | PL202206B1 (enExample) |
| WO (1) | WO2000047049A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1158868B1 (en) * | 1999-03-05 | 2004-06-16 | The Iams Company | Process for preserving skeletal muscle mass in geriatric dogs |
| US6582752B2 (en) * | 2001-11-02 | 2003-06-24 | Nestec, Ltd | Methods and compositions for a gender specific diet for puppies |
| EP1617805A4 (en) * | 2003-04-11 | 2012-07-04 | Medimmune Llc | METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS |
| US9827314B2 (en) | 2003-12-08 | 2017-11-28 | Mars, Incorporated | Edible compositions which are adapted for use by a companion animal |
| US8529965B2 (en) | 2007-07-09 | 2013-09-10 | Hill's Pet Nutrition, Inc. | Compositions and methods for altering stool quality in an animal |
| EP2178391B1 (en) * | 2007-07-09 | 2014-06-04 | Hill's Pet Nutrition, Inc. | Compositions and methods for altering stool quality in an animal |
| GB201120989D0 (en) | 2011-12-06 | 2012-01-18 | Mars Inc | Genetic test |
| EP3081265A1 (en) | 2012-04-17 | 2016-10-19 | Big Heart Pet Brands | Appetizing and dentally efficacious animal chews |
| US9737053B2 (en) | 2012-04-17 | 2017-08-22 | Big Heart Pet, Inc. | Methods for making appetizing and dentally efficacious animal chews |
| GB201310558D0 (en) | 2013-06-13 | 2013-07-31 | Mars Inc | Genetic test |
| JP5911918B2 (ja) * | 2014-06-30 | 2016-04-27 | ユニ・チャーム株式会社 | ペットフードの製造方法 |
| JP2022540664A (ja) * | 2019-07-12 | 2022-09-16 | スティヒティング・ヘット・ネーデルランズ・カンカー・インスティテュート－アントニ・ファン・レーウェンフック・ゼィークンホイス | 石灰化減少に用いる経口ピロリン酸二ナトリウム |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1143399A (en) * | 1965-10-29 | 1969-02-19 | Jack Leonard Harvey | Improvements relating to foods for pet animals |
| US4044158A (en) | 1975-07-23 | 1977-08-23 | The Quaker Oats Company | Caseinate replacement for pet food using a neutral chelating agent |
| US4127678A (en) | 1975-07-23 | 1978-11-28 | The Quaker Oats Company | Caseinate replacement in semi-moist pet foods |
| US4039689A (en) | 1976-02-03 | 1977-08-02 | The Quaker Oats Company | Soft dry pet food product and process |
| US4276311A (en) | 1976-06-17 | 1981-06-30 | Mars Limited | Food product and process |
| US4267195A (en) | 1976-09-10 | 1981-05-12 | University Of Texas | Dog food flavors |
| US4215149A (en) | 1978-11-17 | 1980-07-29 | Standard Brands Incorporated | Process for improving the palatability of pet food |
| JPS5944019B2 (ja) | 1979-09-14 | 1984-10-26 | 株式会社上野製薬応用研究所 | 保存性の良好な中湿度飼料の製造法 |
| US4514431A (en) | 1983-06-23 | 1985-04-30 | International Flavors & Fragrances Inc. | Enhancing the taste of a meat-flavored foodstuff |
| GB8502124D0 (en) | 1985-01-29 | 1985-02-27 | Spillers Foods Ltd | Pet food |
| US4806340A (en) | 1985-09-13 | 1989-02-21 | Colgate-Palmolive Company | Anticalculus oral composition |
| US4772476A (en) | 1986-03-12 | 1988-09-20 | Ralston Purina Company | Method for reducing the severity of hip joint laxity in dogs |
| US5114704A (en) | 1989-05-30 | 1992-05-19 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
| US5015485A (en) | 1989-05-30 | 1991-05-14 | Nabisco Brands, Inc. | Dog biscuits having a coating containing an inorganic pyrophosphate |
| US5047231A (en) | 1989-05-30 | 1991-09-10 | Nabisco Brands, Inc. | Raw hide containing an inorganic pyrophosphate |
| US5000940A (en) | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Devices, compositions and the like having or containing an inorganic pyrophosphate |
| US5000943A (en) | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Canine biscuits containing an inorganic pyrophosphate |
| US5011679A (en) | 1989-05-30 | 1991-04-30 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
| US5094870A (en) | 1989-05-30 | 1992-03-10 | Nabisco Brands, Inc. | Canine biscuits containing an inorganic pyrophosphate |
| US5000973A (en) | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Nutritionally-balanced canine biscuits containing an inorganic pyrophosphate |
| US5000490A (en) * | 1989-12-11 | 1991-03-19 | Albrecht David E | Adapter fitting |
| US5186964A (en) | 1990-09-04 | 1993-02-16 | Applied Food Biotechnology, Inc. | Flavor composition for pet food |
| US5296209A (en) | 1992-01-17 | 1994-03-22 | Colgate Palmolive Company | Pet chew product having oral care properties |
| US5391743A (en) | 1992-05-29 | 1995-02-21 | Procter & Gamble Pharmaceuticals, Inc. | Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque |
| US5296217A (en) | 1992-06-15 | 1994-03-22 | Indiana University Foundation | Methods for preventing dental calculus in domestic animals |
| US5618518A (en) | 1995-06-06 | 1997-04-08 | Indiana University Foundation | Methods and compositions for use against dental calculus in domestic animals |
-
1999
- 1999-02-09 US US09/247,763 patent/US6261591B1/en not_active Expired - Lifetime
-
2000
- 2000-02-08 WO PCT/US2000/003186 patent/WO2000047049A1/en not_active Ceased
- 2000-02-08 DE DE60028935T patent/DE60028935T2/de not_active Expired - Lifetime
- 2000-02-08 EP EP00913388A patent/EP1150569B1/en not_active Expired - Lifetime
- 2000-02-08 ES ES00913388T patent/ES2265922T3/es not_active Expired - Lifetime
- 2000-02-08 AU AU34845/00A patent/AU776992B2/en not_active Expired
- 2000-02-08 PL PL350157A patent/PL202206B1/pl not_active IP Right Cessation
- 2000-02-08 JP JP2000598009A patent/JP4080695B2/ja not_active Expired - Lifetime
- 2000-02-08 HU HU0105485A patent/HUP0105485A2/hu unknown
- 2000-02-08 BR BR0008089-6A patent/BR0008089A/pt not_active Application Discontinuation
- 2000-02-08 KR KR1020017009963A patent/KR100676589B1/ko not_active Expired - Fee Related
- 2000-02-08 HK HK02102174.2A patent/HK1040592B/en not_active IP Right Cessation
- 2000-02-08 CA CA002359874A patent/CA2359874C/en not_active Expired - Lifetime
-
2007
- 2007-07-23 JP JP2007191426A patent/JP4755150B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008017846A (ja) | 2008-01-31 |
| WO2000047049A1 (en) | 2000-08-17 |
| HK1040592A1 (en) | 2002-06-21 |
| ES2265922T3 (es) | 2007-03-01 |
| EP1150569B1 (en) | 2006-06-21 |
| BR0008089A (pt) | 2001-11-06 |
| HUP0105485A2 (hu) | 2002-05-29 |
| JP4755150B2 (ja) | 2011-08-24 |
| HK1040592B (en) | 2007-01-19 |
| JP2002536002A (ja) | 2002-10-29 |
| CA2359874C (en) | 2009-06-30 |
| KR100676589B1 (ko) | 2007-01-30 |
| AU3484500A (en) | 2000-08-29 |
| EP1150569A4 (en) | 2004-10-06 |
| KR20010101812A (ko) | 2001-11-14 |
| US6261591B1 (en) | 2001-07-17 |
| DE60028935D1 (de) | 2006-08-03 |
| CA2359874A1 (en) | 2000-08-17 |
| AU776992B2 (en) | 2004-09-30 |
| DE60028935T2 (de) | 2007-07-12 |
| PL350157A1 (en) | 2002-11-18 |
| EP1150569A1 (en) | 2001-11-07 |
| JP4080695B2 (ja) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4755150B2 (ja) | 股関節弛緩の低減方法 | |
| AU713346C (en) | Cat food composition of improved palatability | |
| US4338336A (en) | Animal feeds for herbivorous animals | |
| PL193847B1 (pl) | Sposób poprawiania walorów smakowych ekstrudowanej karmy dla zwierząt domowych o niskiej lub średniej zawartości wody i kompozycja poprawiająca walory smakowe ekstrudowanej karmy dla zwierząt domowych o niskiej lub średniej zawartości wody | |
| RU2306716C2 (ru) | Способ увеличения массы и роста щенков и корм для щенков, подобранный с учетом их пола | |
| JP2006503567A (ja) | 高齢ネコ科動物フード | |
| DK166006B (da) | Proteinholdigt foder til droevtyggere beskyttet mod nedbrydning i vommen med zinksalte, samt fremgangsmaade til fremstilling heraf | |
| US4772476A (en) | Method for reducing the severity of hip joint laxity in dogs | |
| Wilcke et al. | FEATHERING, GROWTH, FEED CONSUMPTION, AND | |
| CA1068535A (en) | Dietary animal feed composition | |
| CA1305351C (en) | Method and composition for reducing the severity of hip dysplasia in animals | |
| MXPA01008039A (en) | Method for reducing hip joint laxity | |
| WO1988006410A1 (en) | Animal feedstuff | |
| RO138679A2 (ro) | Sistem tehnologic pentru producerea furajelor granulate bio pentru păsări | |
| CA2244751C (en) | Cat food composition of improved palatability | |
| Lewis et al. | Effect of diet on the ether-extract content of chicken muscles | |
| CA1053064A (en) | Caseinate replacement for pet food having a neutral chelating agent | |
| WILCKE et al. | Nutrition Division, Bureau of Animal Industry, United States Department of | |
| Alvarado | Fishmeal substituted for soybean meal fed at two TDN levels for lactating dairy cows | |
| Reece et al. | EC92-210 Swine Diet Suggestions | |
| WO1989005100A1 (en) | Compositions for use in animal husbandry and method of treatment of animals with vitamin u | |
| NZ192299A (en) | Foodstuff containing milk product powder and fatty substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20100208 |